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Abstract
Background—Approximately 1.5 million Americans are affected by Parkinson's disease [1] 
which includes the symptoms of postural instability and gait dysfunction. Currently, clinical 
evaluations of postural instability and gait dysfunction consist of a subjective rater assessment of 
gait patterns using items from the Unified Parkinson's Disease Rating Scale, and assessments can 
be insensitive to the effectiveness of medical interventions. Current research suggests the 
importance of cycling for Parkinson's disease patients, and while Parkinson's gait has been 
evaluated in previous studies, little is known about lower extremity control during cycling. The 
purpose of this study is to examine the lower extremity coordination patterns of Parkinson's 
patients during cycling.
Methods—Twenty five participants, ages 44-72, with a clinical diagnosis of idiopathic 
Parkinson's disease participated in an exercise test on a cycle ergometer that was equipped with 
pedal force measurements. Crank torque, crank angle and power produced by right and left leg 
were measured throughout the test to calculate Symmetry Index at three stages of exercise (20 
Watt, 60 Watt, maximum performance).
Findings—Decreases in Symmetry Index were observed for average power output in Parkinson's 
patients as workload increased. Maximum power Symmetry Index showed a significant difference 
in symmetry between performance at both the 20 Watt and 60 Watt stage and the maximal 
resistance stage. Minimum power Symmetry Index did not show significant differences across the 
stages of the test. While lower extremity asymmetries were present in Parkinson's patients during 
© 2014 Elsevier Ltd. All rights reserved.
Corresponding Author: Jay L. Alberts, PhD Cleveland Clinic 9500 Euclid Ave./ND20 Cleveland, OH 44195 USA Phone: 
216-445-3222 Fax: 216-444-9198 albertj@ccf.org. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Clin Biomech (Bristol, Avon). Author manuscript; available in PMC 2015 December 01.
Published in final edited form as:
Clin Biomech (Bristol, Avon). 2014 December ; 29(10): 1089–1094. doi:10.1016/j.clinbiomech.
2014.10.006.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
pedaling, these asymmetries did not correlate to postural instability and gait dysfunction Unified 
Parkinson's Disease Rating Scale scores.
Interpretation—This pedaling analysis allows for a more sensitive measure of lower extremity 
function than the Unified Parkinson's Disease Rating Scale and may help to provide unique insight 
into current and future lower extremity function.
Keywords
Parkinson's disease; pedaling; postural instability; UPDRS; Exercise test; Posture; Balance; Gait 
dysfunction
Parkinson's disease (PD) [1] affects nearly 1.5 million Americans with medical treatment 
costs approaching $25 billion annually. According to current models of basal ganglia 
function, changes in the pattern and rate of neuronal activity in the basal ganglia result in a 
decrease in motor cortical activation in PD patients [2]. This decreased motor activation may 
limit PD patients’ ability to generate and coordinate voluntary movements, including gait 
and postural stability. Postural instability and gait dysfunction are two of the four cardinal 
motor symptoms of PD which include bradykinesia, resting tremor, rigidity and postural 
instability and gait dysfunction. Clinical evaluation of postural instability and gait 
dysfunction involves examining balance and walking patterns through subjective assessment 
using the Unified Parkinson's Disease Rating Scale (UPDRS) [3, 4]. Postural instability and 
gait dysfunction is rated in this exam on a scale from 0-4, with higher scores indicating 
greater deficits. These deficits affect activities of daily living and may necessitate assistive 
walking devices to compensate for loss of lower extremity and postural control. Despite 
postural instability and gait dysfunction having significant impact on activities of daily 
living and quality of life, the UPDRS postural instability and gait dysfunction measures only 
comprise two out of the eighteen Motor-III assessment questions [5, 6]. This suggests that 
not all factors of postural instability and gait dysfunction are assessed during the UPDRS 
exam.
Pedaling, like walking, is a bipedal motor task, with both activities requiring the same 
principles of lower extremity coordination and rhythmic pattern generation [7-10]. Due to 
the similarities of these tasks, it is reasonable to suggest that dysfunction or asymmetry 
present in one of these activities may also be present in the other. Therefore, the 
quantification of pedaling kinetics, which allows for a more precise measure of lower 
extremity function than the two assessment questions on the UPDRS, in a clinical 
population with gait impairments may be useful for clinicians in the determination of 
postural instability and gait dysfunction. Cycling kinetics, which have not been used 
traditionally as a clinical diagnostic tool for neurological disorders such as PD, are not well 
documented in any disease population, despite the fact that cycling is often recommended 
for rehabilitation or exercise in neurological populations [11-15]. Pedaling kinetics during 
cycling has been well described for young, healthy populations [16-20]. While this is 
valuable in efforts to improve cycling efficiency in athletes, this data can also serve as 
normative data for comparative analysis within clinical populations as well. The 
identification and characterization of deviations from the typical pedaling motion could be 
beneficial in assessing lower extremity function in individuals with movement impairments. 
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Understanding pedaling kinetics in these disease populations may be useful in tracking 
disease progression, measuring intervention efficacy, or lending insight into specific areas of 
function to be targeted for intervention. Recently, we have shown that a “forced-exercise” 
intervention, delivered via stationary tandem bicycle, resulted in a significant improvement 
in global motor functioning of PD patients [21]. In this initial study, pedaling kinetics was 
not quantified although it would have been useful to determine lower extremity function and 
possible alteration.
Lower extremity asymmetry and how it relates to postural instability and gait dysfunction 
has not yet been studied in a PD population. The primary metric of interest in PD pedaling 
kinetics is the symmetry of power output during pedaling. During one pedaling revolution, 
each limb provides a maximal torque at approximately 100 degrees when the leg is pushing 
on the pedal (downstroke), through which it powers the motion of the bicycle. This maximal 
torque is contraposed by the opposite leg generating a smaller and negative torque, when the 
leg is effectively “pulling up” the other pedal (upstroke) (see Figure 1). In order to quantify 
the pedaling motion, this maximum and minimum generated torques, along with the average 
torque generated for each revolution, must be measured, and the outputs from each limb 
during the same revolution are then able to be compared using a Symmetry Index (SI). 
These SI values provide insight into the pedaling coordination of the maximum and 
minimum outputs and of the average level of function during each revolution.
Power output of the lower extremity, which is directly related to crank torque, is an indicator 
of cycling performance [22]. This relationship allows for identification of lower extremity 
asymmetries through examination of crank torque produced during pedaling. Healthy 
individuals, including both recreational and competitive cyclists, exhibit some degree of 
interlimb asymmetry, ranging from five to twenty percent, during pedaling [23] with the 
dominant leg applying greater torque. Though these asymmetries are present, studies have 
shown that they become less pronounced as pedaling rate increases from 60 rpm to 80 rpm 
[23], from 40 rpm to 100 rpm [24], and from 60 rpm to 120 rpm [25]. These previous studies 
suggest that while some low extremity asymmetries may be the norm, they are not great 
enough to affect normal daily activity.
Despite the prevalence of pedaling kinetics characterization in healthy adults, pedaling 
kinetics in clinical populations such as PD has received relatively little attention. The aim of 
this project was two-fold: 1) characterize the pedaling kinetics in PD patients during a 
maximal effort graded exercise test (GXT); and, 2) assess the relationship between measures 
of pedaling kinetics and clinical measures of gait and postural stability. It was hypothesized 
that pedaling asymmetries would be found in PD patients, to a similar degree as found in 
healthy populations, and that these asymmetries would show positive association with 
clinical measures of gait and postural stability, with worsening clinical ratings 
corresponding to increased cycling asymmetry.
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METHODS
Participants
Twenty five participants, (males n=11 ; females n=14 ) ranging from 44-72 years of age, 
with a clinical diagnosis of idiopathic Parkinson's disease and who were Hoehn and Yahr 
stage II-III when off anti- parkinsonian medication were eligible to participate (see Table 1 
for demographics). Individuals with existing cardiopulmonary disease, stroke, dementia, 
diabetes mellitus, or any medical or musculoskeletal contraindication to exercise were 
excluded. Evaluation of inclusion criteria was made based on the patient's medical history 
and physical examination. All participants were recruited from the Cleveland Clinic or local 
neurology offices and phone-screened using questionnaires pertaining to inclusion and 
exclusion criteria and also the American Heart Association/American College of Sports 
Medicine exercise pre-participation screening. Prior to participation, all patients read and 
signed the informed consent approved by the Cleveland Clinic Institutional Review Board.
Procedures
Participants meeting the inclusion criteria were asked to make two visits to the Cleveland 
Clinic in Cleveland, Ohio. Visits were separated by at least 24 hours, but no more than 72 
hours. On the first visit, after obtaining informed consent, participants were clinically 
assessed for PD by a Movement Disorders Neurologist and rated using the UPDRS Part-III 
Motor Exam (mean = 1.28, SD = 0.84) while “off” anti-parkinsonian medication for at least 
12 hours prior to examination (UPDRS gait: mean = 0.76, SD = 0.66; UPDRS posture: mean 
= 0.52, SD = .59).
On the second visit, patients were asked to undergo a graded maximal oxygen uptake 
exercise test (VO2) done on a cycle ergometer (Lode Excalibur Sport with Pedal Force 
Measurement, Lode B.V., Groningen, Netherlands), which was fitted to each participant. 
Patients reported to their appointment “on” their anti-parkinsonian medication and having 
fasted from food and drink, except water, for four hours and caffeine for at least 12 hours. 
Anthropometric recordings of height and weight (Seca 644, Hamburg, Germany) were 
recorded and medical history was taken. Patients were familiarized with the cycle 
ergometer, standard 12-lead electrocardiogram and ratings of perceived exertion Borg scale 
(RPE) to be utilized during the protocol. Electrocardiogram (Welch Allyn, Cardioperfect, 
Skaneateles Falls, NY) was monitored throughout the entire graded exercise test (GXT), 
with blood pressure and RPE taken during the last 15 seconds of every stage. VO2 was 
recorded throughout the GXT via indirect calorimetry using a calibrated metabolic cart 
(Medgraphics, Minneapolis, MN) with each patient fitted with a mouthpiece and nose clips. 
Crank torque and power output per limb were measured throughout the cycle test using 
strain gauges built into the crank arms of the cycle ergometer (Lode Excalibur Sport with 
Pedal Force Measurement, Lode B.V., Groningen, Netherlands). Each enrolled patient 
successfully completed the protocol.
Patients began with a five-minute supine rest prior to the warm-up phase of the GXT. The 
warm-up phase consisted of three minutes cycling at 20W resistance at a self-selected 
pedaling cadence. Patients were encouraged to maintain this self-selected cadence 
Penko et al. Page 4
Clin Biomech (Bristol, Avon). Author manuscript; available in PMC 2015 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
throughout the GXT. After warm-up, each stage lasted two minutes in length with 20W 
increases until stage four (minute eight) when 40W increases were made until volitional 
exhaustion, or until the American College of Sport Medicine test termination criteria was 
met [26]. Three minutes of recovery cycling at 20W was completed by each patient. This 
test is a modification of previously described protocols used in the PD population [27, 28].
Based on torque data measured for each limb, a Symmetry Index (SI) was calculated for 
each 360-degree pedal revolution. The Symmetry Index formula was applied to each pedal 
revolution of the GXT, using the average power (AveSI), maximum power (MaxSI), and 
minimum power (MinSI) generated by each limb at each revolution. A positive SI indicated 
a greater contribution by the unaffected limb and a negative SI indicated a greater 
contribution from the affected limb.
In reviewing the cycling kinetics of the PD participants, it was observed that there typically 
was a portion of the pedal cycle near top and bottom dead center in which the net torque 
produced about the crank axle was very low, much lower than that typically displayed by a 
healthy, recreational cyclist [29]. The duration of this low torque (LTD) was calculated for 
each full 360-degree pedal revolution as the number of degrees of the pedal cycle in which 
the net torque exerted on the pedals by both legs was below ten percent of that revolution's 
maximum net torque output. Higher proportions of the pedal revolution spent at this low 
torque level are indicative of a less smooth pedaling pattern (see Figure 1.).
Three stages of exercise were selected for further analysis, as each patient completed at 
minimum 3 stages of the cycle test. The first stage represents a low intensity workload, the 
initial 20W stage of the GXT; the second stage represents a moderate workload, 60 W; and 
the last stage represents a maximal intensity workload, each subject's final completed stage.
Data Analysis
All data were analyzed using MATLAB. Statistical analysis was performed using the SPSS 
statistical software (SPSS 18, IBM SPSS software, Armonk, NY.). Significance level for all 
analyses was set at P<0.05. A repeated measures analysis of variance was used to test for 
differences between the three stages of exercise and the different measures of SI (AveSI, 
MaxSI, MinSI) and LTD. Greenhouse Geyser adjustment was reported when the sphericity 
assumption was violated. Post hoc contrasts (Bonferroni adjustment) were used to determine 
differences between the three stages. To assess the relationship between measures of 
pedaling kinetics and clinical measures of gait and postural stability, bivariate Pearson 
correlations were calculated.
RESULTS
Pedaling cycles were averaged for each workload. Example plots of individual leg torque 
and net torque throughout the pedaling cycle are shown for one participant in Figure 1. 
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Asymmetry between affected and unaffected side lower limbs can be seen in the difference 
in magnitude at peak output during the pedaling cycle.
For differences between exercise stages, AveSI (F(1.04, 24.89) = 13.32, p = .001, η2 = .
357), MaxSI (F(1.50, 35.98) = 6.78, p = .006, η2 = .220) and LTD (F(1.38, 35.54) = 13.32, p 
< .001, η2 = .597) were found to exhibit a significant effect of exercise stage, whereas for 
MinSI, effect was not significant (F(1.59, 38.26) = 1.62, p = .214, η2 = .063) (See Table 1.). 
AveSI and LTD were significantly different at all three stages of exercise (20W, 60W, 
maximum workload), with positive AveSI values decreasing from 20W (1.18) to maximum 
workload (0.13) and LTD decreasing from 20W (73.17°) to maximum workload (41.77°). 
MaxSI at 20W and 60W was significantly different from MaxSI at maximum workload. 
Also MaxSI decreased with increasing exercise load. That means the contribution of the 
affected limb increased with increasing exercise load in AveSI and MaxSI (see Figure 2).
For relationships between measures of pedaling kinetics and measures of gait and posture, 
we did not find a significant correlation between measures of pedaling kinetics (symmetry 
indices, torque measure) and measures of gait and posture (r = .01 to r = .31; .always p > .
05), with one exception: MinSI at maximum revolution correlated significantly with posture 
(r = .41, p = .04) (see Table 2.).
DISCUSSION
Postural instability and gait dysfunction are two indicators of motor deficits in PD patients. 
Interventions targeted at alleviating this issue is of great importance as it affects ADL's. 
Characterizing pedaling in PD patients may provide insight into potential future issues with 
postural instability and gait dysfunction and also provide a measurement that is a more 
sensitive assessment of lower extremity function than the current scale, the UPDRS. 
Understanding pedaling and subsequent asymmetries in a PD population would provide a 
baseline for comparison of effectiveness of interventions targeting postural instability and 
gait dysfunction, especially when compared with the clinical UPDRS ratings of those 
symptom deficits.
Decreases in SI (symmetry increases) were observed for average power output in PD 
patients as workload increased from the initial 20W stage to the intermediate 60W stage and 
finally to the maximal exertion stage of the exercise test. Maximum power SI showed a 
significant difference in symmetry between performance at both the 20W and 60W stage 
and the maximal resistance stage. Minimum power SI did not show significant differences 
across the three selected stages. Average power proved to be the most asymmetrical of the 
three metrics, with greater SI at earlier stages when compared to maximum and minimum 
power (Figure 2). This finding parallels with data from healthy populations. It was 
hypothesized that pedaling asymmetries would be found in PD patients, to a similar degree 
as found in healthy populations. As expected, based on literature research on healthy norms, 
SI values decreased (showing increased symmetry) with increasing workload. SI values 
generated from maximum and minimum power values were within normal ranges of 
asymmetry (less than 20%).
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The finding that the variability in pedaling, otherwise seen in the SD for SI, decreased from 
20W to 60W to the last stage in the exercise test is of particular interest. Previous studies 
have shown that PD patients experience a decrease in the quantity, quality and processing of 
afferent information which is thought to be a result of decreased cortical activation [30, 31]. 
Increased variability in pedaling kinetics may contribute to the decrease in the quality and 
processing of afferent information. The results of this study, have shown variability in 
pedaling motion in individuals with PD. The findings may help to support a need for a 
therapeutic intervention that provides higher quality and quantity afferent information via 
augmenting the pedaling motion. An intervention such as forced-exercise could potentially 
aid in better afferent processing, leading to improvement or alleviation of postural instability 
and gait dysfunction and an increase in quality of life.
Based on the relationships observed with the maximum and minimum torques, the extrema 
of the overall torque profiles are consistent in magnitude across stages of the exercise test. 
At the same time, the symmetry of the average power output is increasing with increasing 
resistance. In investigating these phenomena, a “low torque” area of varying duration was 
found in the net torque profile. This LTD indicated that a larger portion of each pedaling 
revolution is spent exerting negative torque (i.e. pulling up on the pedal or not exerting 
significant torque) and that the drive lower extremity was contributing a more gradual 
increase in torque. This combination seemed to contribute to the “low torque area.” 
Increased “pull” by the leg at back end of pedaling circuit leads to increased negative 
torques that effectively cancels out normal or decreased positive torque by the other limb, 
the drive lower extremity. Especially at lower resistance stages, this LTD is highly variable 
in length, lending credence to the idea that it is a measure of subject engagement and 
symmetry. With increasing resistance, the “need” for symmetry and an efficient pedaling 
motion seems to curtail this LTD down to less than 12% of the pedaling cycle from over 
20% at the initial stage.
The secondary hypothesis was that pedaling asymmetries that were found in individuals 
with PD would show positive association with clinical measures of gait and postural 
stability, with worsening clinical ratings corresponding to increased cycling asymmetry. The 
anticipated relationship between pedaling asymmetry and postural instability and gait 
dysfunction scores on the UPDRS was not found in this study. While cycling kinetics has 
not traditionally been used as a clinical tool for patients with PD, we have shown that even if 
asymmetries are present, the UPDRS may not be sensitive enough to detect these 
asymmetries. The subjective nature of the UPDRS evaluation limits the precision with 
which postural instability and gait dysfunction can be quantified, as seen in the SI during 
low resistance pedaling. Since no relationship between postural instability and gait 
dysfunction and SI was determined in this study despite evidence suggesting the presence of 
asymmetries, perhaps the UPDRS may be relatively insensitive to the effectiveness of 
medical or surgical intervention.
Study limitations
Our research included those with PD who were mild to moderate in their disease state. 
Therefore, our results may only be applicable to a subset of the PD population. We also did 
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not take into account if there were differences between genders. Future research expanding 
to PD patients with severe motor impairments, and also research studying gender differences 
in PD may help to clarify and improve our findings. Furthermore, patients reported to their 
GXT visit on their anti-parkinsonian medication and the UPDRS exam was preformed off 
their antiparkinsonian medication. Ideally, clinical assessments and metabolic testing would 
have been completed while patients were in the “on” and “off” medication states. The 
additional burden required of the patient to be “off” medication for additional sessions led to 
the decision to not collect kinetic and clinical data in all phases of medication. Future 
research investigating pedaling patterns compared to the UPDRS while patients are in 
similar medicated states may be helpful to further reveal the relationship between clinical 
ratings of PD and PIGD.
CONCLUSION
In summary, it was found that lower extremity asymmetries were present in PD patients 
during pedaling on a cycle ergometer during a graded, maximal effort exercise stress test, 
and that these asymmetries decreased with increases in workload. It was also found that 
asymmetries in pedaling did not correlate to scores of postural instability and gait as rated 
using the UPDRS. Future studies are needed to determine how to minimize postural 
instability and gait dysfunction in PD patients through therapeutic interventions and to 
develop more sensitive diagnostic tools for more effective measurement of postural 
instability and gait dysfunction in neurological populations. Demonstrating that PD patients 
exhibit asymmetrical pedaling kinetics provides support for an intervention, such as forced 
exercise, that attempts to normalize patient's movement symmetry. The characterization of 
pedaling kinetics in PD patients may be useful clinically for early detection of gait and 
postural instability caused by disease progression. Earlier detection may provide an 
opportunity for more effective intervention to offset the advance and severity of the 
imbalances.
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Highlights
• Pedaling kinetics were characterized in a Parkinson's disease population
• The relationship between pedaling kinetics and clinical measures of gait and 
postural stability were assessed
• Asymmetries in pedaling kinetics of PD patients were found
• Pedaling asymmetries were not correlated to clinical measures of gait and 
postural instability scores
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Figure 1. 
Example plots of one participant's individual leg torque profiles (A-C; Affected Side in red 
and Unaffected Side in blue) and Net Torque profiles (D-F) for all pedal revolutions during 
20W (A & D), 60W (B & E), and Maximum (C & F) Workloads. The area of low torque 
duration (LTD) is also displayed in the Net Torque profiles.
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Figure 2. 
Results of the symmetry indices (average power (AveSI), maximum power (MaxSI), and 
minimum power (MinSI)) and the torque profile (duration of low torque (LTD)) at 20W, 
60W and maximum workload (MW) (for SD see Table 1). A star marks significant changes 
(p < .05), a star (*) marks marginally significant changes (p < .10) between workloads.
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Table 1
Participant demographics
Participant Age (yrs) Disease Duration (yrs) VO2max (ml/kg/min) Maximal 
Exercise 
Stage (W)
UPDRS Total Score UPDRS Posture Score UPDRS Gait Score
1 52 6 31.6 220 9 0 0
2 58 9 15 80 31 1 1
3 59 6 21.6 100 20 0 0
4 44 8 29.4 140 34 2 1
5 67 5 21.9 140 27.5 0 1
6 72 5 12.4 80 6 0 0
7 61 5 21.9 180 13 2 1
8 56 1 16.5 80 31 1 1
9 56 2 28.1 180 15 1 0
10 70 0.5 26.2 180 18 1 0
11 50 3 27.1 140 15 0 1
12 53 0.5 20.6 180 14 0 0
13 71 3 20.4 100 27 0 2
14 47 1 25.1 220 19 0 1
15 57 2 25.7 140 14 0 1
16 71 2 18.7 140 37 1 0
17 53 4 18.7 100 24 1 1
18 65 0.5 17.6 80 16 1 0
19 67 9 22.5 80 24 1 2
20 51 4.5 12.5 80 15 0 2
21 67 1 20.4 180 23 1 0
22 66 10 15.9 80 25 0 1
23 45 1.5 30.9 260 35 0 1
24 58 0.5 20.6 80 15 0 0
25 60 0.5 22.4 100 22 1 1
Mean and SD 59.04 ± 8.45 3.62 ± 3.01 21.75 ± 5.32 133.6±53.76 21.18 ± 8.30 .56 ± .65 .72 ± .68
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Table 2
Pearson product moment correlations for clinical measures (UPDRS_total (UPDRS), gait, posture) and 
pedaling kinetics (AveSI, MaxSI, MinSI, LTD) at each revolution (20W, 60W, maxW).
Variables UPDRS gait posture
1. AveSI_20W −.18 .02 −.27
2. AveSI_60W −.06
.06* −.15
3. AveSI_max −.06 −.16 .10
1. MaxSI_20W −.12 .03 −.21
2. MaxSI_60W −.07 .01 −.10
3. MaxSI_max .05 −.10 .19
1. MinSI_20W .11 −.08 .26
2. MinSI_60W −.17 −.29 .08
3. MinSI_max .31 .02
.41*
1. LTD_20W .14 .05− .14
2. LTD_60W .10 .07 .07
3. LTD_max .17 .04 .21
Note.
*p < .05
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